Stock listing
60 Degrees Pharmaceuticals, Inc.
Selected listing: SXTP · NASDAQ · USD · US
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP), Health Technology. Latest release Oct 6, 2026: 60 Degrees Pharmaceuticals Plans January 2027 Hospitalized…
- Ticker
- NASDAQ:SXTP
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. is a public company traded under the ticker SXTP in the American market. 60 Degrees Pharmaceuticals focuses on developing innovative therapies for various medical conditions.
Latest news from 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA
October 5, 2026
60 Degrees Pharmaceuticals and Exyn Technologies Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
October 1, 2026
60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar
October 1, 2026
60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar
September 30, 2026
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
Research 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. company profile
View the public company page for 60 Degrees Pharmaceuticals, Inc. on 6ix.
60 Degrees Pharmaceuticals, Inc. news
Read company news and market updates connected to 60 Degrees Pharmaceuticals, Inc..
60 Degrees Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for 60 Degrees Pharmaceuticals, Inc..